智通财经网·2025-11-13 14:50Core Viewpoint - *ST Ningke (600165.SH) and its subsidiaries have received court approvals for their restructuring plans, marking the end of their restructuring processes [1] Group 1 - The company and its subsidiaries, Ningxia Zhongke Biological New Materials Co., Ltd. and Ningxia Xinhai Hengli International Trade Co., Ltd., received civil rulings from the Intermediate People's Court of Shizuishan, Ningxia Hui Autonomous Region [1] - The court approved the restructuring plans for Ningxia Zhongke Biotechnology Co., Ltd., Ningxia Zhongke Biological New Materials Co., Ltd., and Ningxia Xinhai Hengli International Trade Co., Ltd. [1] - The restructuring procedures for the company and its subsidiaries have been terminated following the court's decision [1]